Scientific advisers to the US Food and Drug Administration have voted overwhelmingly against Pfizer’s application to offer a third shot of its Covid-19 vaccine to everyone over 16, dealing a serious blow to the Biden administration’s plans for a widespread booster programme.
Members of the regulator’s vaccine advisory committee voted 16-2 on Friday against endorsing a booster of the two-dose BioNTech/Pfizer vaccine for Americans aged 16 or older at least six months after receiving their second shot.
They subsequently voted unanimously to authorise a third shot only for over-65s, anyone at high risk of contracting severe Covid-19, and people whose jobs expose them to the virus, such as healthcare workers.
您已閱讀15%（712字），剩余85%（4050字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。